polycystic kidney disease 5

ORPHA: 731

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with polycystic kidney disease 5, sourced from HPO and Orphanet clinical annotations.

Enlarged kidneyPolycystic kidney dysplasiaHypertensionHepatic fibrosisPeriportal fibrosisRenal insufficiencyCholestasisPortal hypertensionGrowth delayOligohydramniosSplenomegalyHypersplenismEsophageal varixPulmonary hypoplasiaCongenital hepatic fibrosisFat malabsorptionRespiratory failureHyponatremiaStage 5 chronic kidney diseaseReduced circulating vitamin A concentrationReduced renal corticomedullary differentiationBiliary hyperplasiaAbnormal intrahepatic bile duct morphologyDecreased circulating vitamin K concentrationFeeding difficultiesIncreased serum bile acid concentrationElevated gamma-glutamyltransferase levelDecreased circulating vitamin D concentrationDecreased circulating vitamin E concentrationRecurrent urinary tract infectionsJaundiceHepatosplenomegalyAscitesThrombocytopeniaAcute kidney injuryPolydipsiaGastrointestinal hemorrhageProtein-losing enteropathyHypoventilationHepatoblastomaRecurrent pneumoniaCholangitisOliguriaMicrognathiaLow-set earsDepressed nasal ridgePancreatic cystsSpontaneous pneumothoraxCholangiocarcinomaAbnormality of limbsCognitive impairment

Classification & Codes

Orphanet Code

ORPHA:731
polycystic kidney disease 5
OrphanetORPHA:731
Treatments0 drug(s)
Symptoms on record51 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO